Site under maintenance

 

 

Cohort Innovation Day

November 5 2025

Imagine Institute, Paris

 

Cohort Innovation Day (CID) is an international event aimed at fostering collaborations between researchers and economic players in the health sector. It provides a unique opportunity to showcase the potential of French cohorts to health companies, whether national or international, ranging from large industries to biotech firms.

For its 2025 edition, CID will take place on November 5th at Institut Imagine in Paris, organized by Ariis (Alliance for Research and Innovation in Health Industries), Medicen (the Health Competitiveness Cluster in Île-de-France), and Inserm.

The event will feature:

  • Plenary sessions and round tables
  • Presentations from participating cohorts
  • Dedicated B2B meetings between companies and cohort representatives

CID offers cohort leaders the chance to connect with economic players, promote their cohorts, and explore new collaborations or strengthen existing ones.

Participating cohorts will be selected through this call for expressions of interest by a scientific committee composed of experts from both academic and private research sectors. Selected cohorts will be featured in the event catalog, participate in B2B meetings, and some will present during plenary sessions.

Cohort leaders wishing to participate are encouraged to submit their applications via the link below. Special attention will be given to cohorts focused on at least one of the following four key therapeutic areas:

  • Immune and Inflammatory Diseases
  • Metabolic and Cardiovascular Diseases
  • Neurodegenerative Diseases
  • Thromboembolic Diseases

However, outstanding cohorts from other fields may also be considered.

Apply Online: Submit your application here


2014 *contenu + mise en forme*

Details
Category: Previous Editions

rir 2013 lg

The 5th International R&D Dating will take place on October 24th in the “Carrousel du Louvre” right in the heart of Paris, on the theme of «Inflammation and inflammatory diseases». This topic, chosen by ARIIS and AVIESAN, is in agreement with the recommendation of the 5th meeting of the Strategic Council of Industries of Health (CSIS) held in January 2012.

Inflammation is part of a complex physiological process and plays a crucial role in the tissue response to harmful stimuli. However, acute or chronic inflammation can induce many diseases. Progress in the elucidation of the mechanisms that regulate inflammation and a reinforced organization of the patient treatment may allow a better medical care and the development of new anti-inflammatory drugs.

Inflammation is a worldwide priority for public health. In France, more than 80 research teams are working on inflammation and/or inflammatory diseases. These teams have made major progresses in the molecular and cellular bases of inflammation, as well as on clinical research, epidemiology, public health and translational research. Altogether, the results obtained result in a better understanding of inflammatory diseases.

The research developed in France is specifically focused on several aspects of inflammation and inflammatory diseases: elucidation of the cellular and molecular mechanisms that regulate inflammation; research on the interactions between components of the immune system during the inflammatory response and its chronicity; development of new experimental models of inflammatory pathologies and technological improvement to follow the onset and the evolution of the inflammatory response; role of the tissue environment and development of new cellular or molecular products targeting the pathways implicated in the early and late stages of the inflammatory response and inflammatory diseases without efficient therapies. Finally, genomic studies leads to the identification of molecular signatures that can be transferred to clinical studies and will allow better diagnosis, prognosis and improvement of treatments of inflammatory diseases.

 


Photos